Vise Technologies Inc. Invests $1.75 Million in MetLife, Inc. $MET

Vise Technologies Inc. bought a new stake in MetLife, Inc. (NYSE:MET) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 21,698 shares of the financial services provider’s stock, valued at approximately $1,745,000.

A number of other institutional investors have also recently bought and sold shares of the business. Allworth Financial LP boosted its stake in shares of MetLife by 13.4% during the 2nd quarter. Allworth Financial LP now owns 10,893 shares of the financial services provider’s stock worth $876,000 after acquiring an additional 1,285 shares during the period. Davis R M Inc. lifted its holdings in MetLife by 5.5% during the 2nd quarter. Davis R M Inc. now owns 3,497 shares of the financial services provider’s stock valued at $281,000 after purchasing an additional 182 shares during the last quarter. Fidelis Capital Partners LLC boosted its position in MetLife by 5.2% during the second quarter. Fidelis Capital Partners LLC now owns 3,613 shares of the financial services provider’s stock worth $274,000 after purchasing an additional 180 shares during the period. PFG Advisors bought a new position in MetLife during the second quarter worth $236,000. Finally, Pinnacle Wealth Management Advisory Group LLC increased its holdings in shares of MetLife by 12.3% in the second quarter. Pinnacle Wealth Management Advisory Group LLC now owns 3,356 shares of the financial services provider’s stock valued at $270,000 after purchasing an additional 367 shares during the last quarter. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife Price Performance

Shares of NYSE:MET opened at $77.74 on Wednesday. The firm has a 50 day moving average of $79.90 and a 200-day moving average of $78.89. MetLife, Inc. has a 12 month low of $65.21 and a 12 month high of $89.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.57. The stock has a market capitalization of $51.70 billion, a PE ratio of 13.18, a PEG ratio of 0.70 and a beta of 0.87.

MetLife (NYSE:MET) last announced its quarterly earnings data on Wednesday, November 5th. The financial services provider reported $2.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.30 by $0.07. MetLife had a net margin of 5.83% and a return on equity of 19.88%. The business had revenue of $12.46 billion for the quarter, compared to analysts’ expectations of $18.64 billion. During the same period last year, the firm posted $1.95 earnings per share. The firm’s quarterly revenue was down 5.9% compared to the same quarter last year. On average, equities research analysts predict that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 9th. Investors of record on Tuesday, November 4th will be given a dividend of $0.5675 per share. This represents a $2.27 annualized dividend and a dividend yield of 2.9%. The ex-dividend date is Tuesday, November 4th. MetLife’s dividend payout ratio is currently 42.75%.

Wall Street Analysts Forecast Growth

Several analysts recently commented on MET shares. Keefe, Bruyette & Woods reduced their target price on shares of MetLife from $92.00 to $90.00 and set an “outperform” rating for the company in a report on Tuesday. Wells Fargo & Company reduced their price objective on MetLife from $96.00 to $92.00 and set an “overweight” rating for the company in a report on Friday, November 7th. Morgan Stanley upped their target price on MetLife from $94.00 to $97.00 and gave the company an “overweight” rating in a research report on Tuesday, October 7th. Barclays lifted their price target on MetLife from $93.00 to $98.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of MetLife in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $95.00.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.